Spravato Nasal Spray Technique: Questions to Ask Your Treatment Team
If you worry about coordinating a nasal spray, you are not expected to work it out alone. Spravato nasal spray technique is taught and observed during treatment at a certified healthcare setting. The clinician supplies the prescribed devices, guides administration, and checks what happened if something seems wrong. Your job is to follow that guidance and speak up—not to correct a suspected missed dose yourself.
This guide addresses how to use Spravato with your treatment team's guidance, including questions and common uncertainties during a supervised visit. It is not a take-home dosing protocol, and a technique concern should not be used to blame you for a slow or incomplete treatment response.
Spravato instructions: confirm the exact nasal spray product
The official Spravato administration instructions apply to a particular esketamine nasal spray device. A compounded ketamine spray, an allergy spray, or another nasal medicine is not an interchangeable product. Do not transfer familiar instructions from something you use at home to this supervised treatment.
Before starting, ask the clinician to show you the device and describe the sequence. Tell them if you have difficulty with grip, hand movement, vision, hearing, or following several instructions at once. Asking for a demonstration or one step at a time is part of good communication, not a sign that you are unsuitable for care.
You can also ask what staff will check after administration. Knowing that device delivery is being observed may be more reassuring than trying to remember every detail from a video before arriving.
Preparation includes other nasal medicines and current symptoms
The MedlinePlus esketamine guide explains that patients should tell their clinician about other medicines, including nasal products. Ask the team how prescribed nasal medicines and any congestion or irritation should be handled before that day's visit.
Do not independently add a decongestant, change a prescription, or use a preparation trick to improve absorption. The clinician needs to know what you actually use and when. If you misunderstood an instruction, say so before treatment begins rather than trying to make a private correction.
A useful question is: “I use this nasal medicine, and my nose has felt blocked today. Does that change what we should do?” Describe the product and symptom accurately. The treatment team can then assess the situation instead of having to infer it from a general comment that your technique felt different.
Ask for a demonstration of Spravato nasal spray technique
The general principle in the NIMH guide to communicating with your provider is to ask questions when information is unclear. Applied here, that means requesting demonstration and supervision rather than guessing at the timing of a breath or the position of a device.
The Spravato instructions describe positioning the device as demonstrated, breathing in through the nose while fully pressing the plunger, and sniffing gently afterward. Staff guide the sequence for each nostril and device. Do not turn “gently” into a challenge to inhale more forcefully or seek a stronger sensation.
A clear request might be: “Please talk me through the breath and the press together.” You can explain the part that worries you—coordination, how to hold the device, or what to do after the spray—rather than simply saying you are nervous. That makes it easier for the clinician to address the actual uncertainty.
If something seems wrong, report it before taking another step
If you sneeze, notice liquid dripping, are unsure whether the plunger moved fully, or think the spray missed, tell the supervising clinician immediately. Do not test-spray, prime, add a spray, or repeat administration on your own. The official device instructions do not call for priming.
The clinician can check the device and decide what action, if any, is appropriate. Reporting the event is more useful than interpreting it yourself as a complete missed dose. It also allows staff to record the concern and explain what happens next.
Regardless of how administration felt, the post-administration monitoring requirements still apply. A suspected technique problem is not a reason to skip observation, leave early, or assume that the medicine could not affect you. Continue following the team's directions and report symptoms during the visit.
Do not use taste or intensity as a dose meter
A noticeable taste, nasal sensation, or altered-perception experience can draw your attention, but it is not a reliable way to decide that you need more medicine. You should not try to produce a particular taste or stronger subjective effect to prove that administration was successful.
Tell the clinician what you noticed. Keep the observation separate from the conclusion: “I noticed some liquid” is different from “I did not receive the treatment.” Staff can interpret the event within the supervised process; a blog or another patient's story cannot inspect the device or evaluate your situation.
Likewise, a less intense session does not establish that the technique was wrong. Treatment benefit is assessed through symptoms and functioning over time, alongside safety and tolerability. The experience in the chair should not become a contest to reproduce the strongest effect you have heard described.
When depression is not improving, review the whole plan
A discussion of depression assessment and care should look beyond one possible technique issue. Your clinician can review the treatment delivered, symptom changes, adverse effects, other medicines, and practical barriers to following the plan. Do not accept an unsupported explanation that slow progress must mean you used the device incorrectly.
For adult treatment-resistant depression, the prescribing information calls for evaluating therapeutic benefit after the four-week induction phase. That review is not a reason to hide earlier concerns or wait through significant worsening. Speak up when something needs attention.
Ask: “Was there a documented administration problem, or are we considering other reasons for limited benefit?” A clear answer distinguishes an observed event from speculation. You deserve an understandable reassessment, not a technique trick advertised as the missing key to guaranteed recovery.
Bring a three-question note to your next visit
Before administration, ask which part of the sequence you should watch most closely and request another demonstration when needed. Mention any physical or communication difficulty before medication affects your alertness.
During administration, ask what you should do if you are uncertain that a step happened as intended. Agree that you will pause and alert the clinician instead of attempting an independent correction. This communication plan can be simple enough to remember even when you feel anxious.
Before discharge, ask whether anything about the visit should be discussed at the next review. Follow the written aftercare instructions, including the restriction on driving until the next day after restful sleep. A successful visit includes safe communication and appropriate monitoring; it does not require you to feel expert at handling the device.
Discussing supervised treatment with Sophroneo
Sophroneo Behavioral Health & TMS lists Spravato among its mental health services and provides therapy and counseling. The practice serves the Atlanta area from Powder Springs and Marietta. Contact Sophroneo to confirm treatment availability and location, or bring technique questions to the team supervising your appointment. The clinician's instructions for your actual visit take priority over general online education.
Frequently asked questions
Should I repeat a Spravato spray if I sneeze?
Do not repeat it independently. Tell the supervising clinician what happened and let the team check the device and assess the situation. A sneeze or a sensation alone does not give you enough information to decide that another spray is needed.
Does a stronger sniff make Spravato work better?
Follow the demonstrated official technique rather than trying to intensify it. The instructions describe coordinated breathing during the press and a gentle sniff afterward. There is no basis here for promising greater clinical benefit from inhaling more forcefully.
Can I practice with or keep an unused device at home?
Spravato is administered through a supervised clinical program, not dispensed for independent home use. Ask staff to demonstrate the equipment at the treatment center. Do not test-spray or take a prescribed device away to practice on your own.
In the United States, call or text 988 for emotional crisis support or suicidal thoughts. Call 911 for immediate danger or a life-threatening reaction. Routine treatment contact is not an emergency service.
This article is educational, not independent dosing or administration advice. Use Spravato only as directed within the required supervised setting.
Comments